NorthStar Medical closes $100 million financing with Oberland Capital

NorthStar Medical Technologies closed a $100 million secured financing with Oberland Capital to expand domestic Mo-99 radioisotope production capacity and implement RadioGenix System enhancements.

“This financing agreement with Oberland Capital enables us to execute on our clearly defined strategy to build solid, sustainable momentum for NorthStar as a fully commercial enterprise.”biospace.com

• 1 source
• biospace.comNorthStar Medical Closes $100 Million Financing with Oberland Capital to Expand Domestic Mo-99 Radioisotope Production Capacity and Implement RadioGenix® System Enhancements - BioSpaceGabrielle MassonApr 23, 2019

Summarized from public sources; check the original articles before acting on it.